U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111078) titled 'Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults' on Aug. 07.
Brief Summary: Background:
Influenza (flu) is a contagious respiratory illness caused by viruses. Flu symptoms can range from mild to severe, and the illness can be fatal. Vaccines help the body learn to prevent or fight infections such as flu. Some vaccines are combined with adjuvants. Adjuvants are special salts or fats that help vaccines work better. Researchers are looking for ways to make flu vaccines more effective.
Objective:
To test a new flu vaccine with and without a new adjuvant.
Eligibili...